Clinical Trial Update: Phase II Trial of TIL Following CCRT in Patients With Locoregionally Advanced NPC [Phase 2]

View source ↗

Summary

This document provides an update on a Phase II trial evaluating tumor-infiltrating lymphocytes (TIL) after concurrent chemoradiation in locoregionally advanced …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Tumor-infiltrating lymphocytes (tumor-infiltrating lymphocytes)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN